关注
Tanica Lyngdoh
Tanica Lyngdoh
ICMR
在 icmr.gov.in 的电子邮件经过验证
标题
引用次数
年份
Field based research in the era of the pandemic in resource limited settings: challenges and lessons for the future
R Mulchandani, T Lyngdoh, S Gandotra, HS Isser, RK Dhamija, ...
Frontiers in Public Health 12, 1309089, 2024
2024
Novel genomic variants related to Visceral Adiposity Index (VAI) and Body Adiposity Index (BAI) in Indian Sib-pairs
T Agarwal, T Lyngdoh, R Khadgawat, F Dudbridge, C Relton, ...
Available at SSRN 4604769, 2023
2023
Genetic architecture of adiposity measures among Asians: Findings from GWAS
T Agarwal, T Lyngdoh, R Khadgawat, D Prabhakaran, GR Chandak, ...
Annals of Human Genetics 87 (6), 255-273, 2023
2023
Relationship between serum lipids and depression: A cross sectional survey among adults in Haryana, India
R Mulchandani, T Lyngdoh, R Nangia, S Singh, S Grover, JS Thakur
Indian Journal of Psychiatry 65 (1), 61-67, 2023
32023
Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
S Misra, T Lyngdoh, R Mulchandani
Indian heart journal 74 (5), 341-350, 2022
132022
Factors associated with differential COVID-19 mortality rates in the SEAR nations: a narrative review
R Mulchandani, GR Babu, A Kaur, R Singh, T Lyngdoh
IJID regions 3, 54-67, 2022
112022
Low-cost Particulate Matter Monitor for Field Measurements
P Rajput, A Sharma, T Lyngdoh
NSF Convergence Workshop on Bringing Land, Ocean, Atmosphere and Ionosphere …, 2021
2021
Knowledge, attitude and practice study of health risks among E-waste recyclers in Delhi
D Singhal, T Lyngdoh, P Prabhakaran
Journal of Health and Pollution 11 (29), 210306, 2021
82021
Deciphering the COVID‐19 cytokine storm: systematic review and meta‐analysis
R Mulchandani, T Lyngdoh, AK Kakkar
European journal of clinical investigation 51 (1), e13429, 2021
2452021
Statins-induced hepatotoxicity: still more questions than answers
R Mulchandani, T Lyngdoh, AK Kakkar
Expert Opinion on Drug Safety 19 (12), 1653-1654, 2020
2020
Capacity-building Initiatives in Non-communicable Diseases in India
T Lyngdoh, A Sharma, S Zodpey
Journal of Health Management 22 (3), 363-374, 2020
32020
Relative contribution of diet and physical activity to increased adiposity among rural to urban migrants in India: A cross-sectional study
S Kinra, PAC Mallinson, JA Cresswell, LJ Bowen, T Lyngdoh, ...
PLoS Medicine 17 (8), e1003234, 2020
72020
Statin use and safety concerns: an overview of the past, present, and the future
R Mulchandani, T Lyngdoh, AK Kakkar
Expert Opinion on Drug Safety 19 (8), 1011-1024, 2020
242020
Validation of hindi version of Edinburgh postnatal depression scale as a screening tool for antenatal depression
U Joshi, T Lyngdoh, R Shidhaye
Asian Journal of Psychiatry 48, 101919, 2020
372020
Causal relationships between lipid and glycemic levels in an Indian population: a bidirectional Mendelian randomization approach
T Agarwal, T Lyngdoh, F Dudbridge, GR Chandak, S Kinra, ...
PLoS One 15 (1), e0228269, 2020
102020
Low lung function in the developing world is analogous to stunting: a review of the evidence
N Mishra, S Salvi, T Lyngdoh, A Agrawal
Wellcome Open Research 5, 2020
52020
Satisfaction with statin treatment among adult coronary artery disease patients: An experience from a resource-constrained setting
R Mulchandani, T Lyngdoh, P Chakraborty, AK Kakkar
Heart, Lung and Circulation 28 (12), 1788-1794, 2019
52019
Non-communicable diseases risk factors and their determinants: A cross-sectional state-wide STEPS survey, Haryana, North India
JS Thakur, G Jeet, R Nangia, D Singh, S Grover, T Lyngdoh, A Pal, ...
PLoS One 14 (11), e0208872, 2019
432019
Factors affecting early adult lung function
N Mishra, A Agrawal, S Salvi, C Yajnik, T Lyngdoh, M Aggarwal
European Respiratory Journal 54 (suppl 63), 2019
2019
Treatment Satisfaction In Coronary Artery Disease Patients: Implications Of Statin Safety
R Mulchandani, T Lyngdoh, P Chakraborty, A Kakkar
Atherosclerosis 287, e204, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–20